▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3198 by analyst upside · 2026-11-12
HNGE
Hinge Health, Inc.
Healthcare · Market Cap $10B · P/E 33.0x
ANALYST PRICE TARGET
+11.2%
implied upside to consensus target
Current Price $121.72
Consensus Target $135.38
Bull Target $151.0
Bear Target $90.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
8
Hold
1
Sell
0
52-Week Low $30.08
52-Week High $126.4
YTD Return +167.2%
FUNDAMENTALS
Market Cap $10B
P/E Ratio (TTM) 33.0x
Forward P/E 37.4x
EPS (TTM) $3.69
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $801M
Profit Margin 21.0%
52-WEEK RANGE
52-Week Low $30.08
52-Week High $126.4
Current Price $121.72
Bear Target $90.0
Bull Target $151.0
● Now $121.72 ● Target $135.38
TRADING DATA
Avg Volume 1.9M
YTD Return +167.2%
Analyst Count 16
Consensus Buy
Upside to Target +11.2%
Last Updated 2026-11-12

ANALYST SUMMARY

Hinge Health, Inc. (HNGE) is currently trading at $121.72 with a Wall Street consensus price target of $135.38, implying potential upside of 11.2% over the next 12 months. 16 analysts currently cover HNGE, with a consensus rating of Buy - 94% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $151.0, while the most cautious has a target of $90.0.

HNGE operates in the Healthcare sector with a market capitalisation of $10B. The stock is up 167.2% year-to-date and is currently trading near the upper end of its 52-week range of $30.08 – $126.4.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for HNGE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Freedom Capital Markets - Reiterated
Buy → Buy 2026-11-03 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-11-03 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-11-03 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-11-03 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-11-03 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-11-03 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-11-03 Building track record
Stifel - Reiterated
Buy → Buy 2026-11-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
64
out of 100
Coverage depth
22/30
Consensus clarity
20/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →